Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3905 | Tap water Wiki | 1.00 |
| drug3040 | Povidone-Iodine Wiki | 0.50 |
| drug1127 | DAS181 Wiki | 0.41 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D007251 | Influenza, Human NIH | 0.21 |
| D003141 | Communicable Diseases NIH | 0.07 |
| D007239 | Infection NIH | 0.05 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to assess the ability of regular gargling to eliminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the throat and nasopharynx. This 4 arms interventional study compares the effect of gargling using povidone-iodine, essential oils- based, tap water with control (no intervention) among Stage 1 coronavirus disease-2019 (COVID-19) patients. Findings from this study will provide new insight into the importance of gargling in the treatment and prevention of COVID-19.
Description: Viral clearance is defined as two negative RT-PCR (of swabs from oropharynx and nasopharynx) results at least 24 hours apart
Measure: Number of Participants With Early Viral Clearance Time: Day 6Description: RT-PCR (swabs from oropharynx and nasopharynx) taken at day 12
Measure: Number of Participants With Negative RT-PCR Results Time: Day 12Description: Presence of signs and symptoms of more severe COVID19 Based symptoms diary and clinical evaluation
Measure: Number of Patients That Progress to More Severe Disease Time: Day 12Description: abnormal chest x-ray or CT scan
Measure: Number of Patients With Abnormal Radiological Findings Time: Day 0-14Description: Abnormal absolute lymphocytic count Abnormal C-reactive protein
Measure: Number of Patients With Abnormal Laboratory Findings Time: Day 0-14Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports